Back to Browse Journals » Vascular Health and Risk Management » Volume 3 » Issue 1

What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of: “All that is necessary for the triumph of evil is that good men do nothing?”

Authors Chris R Triggle, David J Triggle

Published Date May 2007 Volume 2007:3(1) Pages 39—53

DOI http://dx.doi.org/

Published 18 May 2007

Chris R Triggle1, David J Triggle2

1School of Medical Sciences, RMIT University, Melbourne, Victoria, Australia; 2School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo NY, USA

Abstract: Peer review is an essential component of the process that is universally applied prior to the acceptance of a manuscript, grant or other scholarly work. Most of us willingly accept the responsibilities that come with being a reviewer but how comfortable are we with the process? Peer review is open to abuse but how should it be policed and can it be improved? A bad peer review process can inadvertently ruin an individual’s career, but are there penalties for policing a reviewer who deliberately sabotages a manuscript or grant? Science has received an increasingly tainted name because of recent high profile cases of alleged scientific misconduct. Once considered the results of work stress or a temporary mental health problem, scientific misconduct is increasingly being reported and proved to be a repeat offence. How should scientific misconduct be handled—is it a criminal offence and subject to national or international law? Similarly plagiarism is an ever-increasing concern whether at the level of the student or a university president. Are the existing laws tough enough? These issues, with appropriate examples, are dealt with in this review.

Keywords: peer review, journal impact factors, conflicts of interest, scientific misconduct, plagiarism

Download Article [PDF] 

Readers of this article also read:

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum]

Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2015, 8:365-366

Published Date: 4 February 2015

Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women

Prasad M, Reriani M, Khosla S, Gössl M, Lennon R, Gulati R, Prasad A, Lerman LO, Lerman A

Vascular Health and Risk Management 2014, 10:533-538

Published Date: 26 August 2014

Characterization, activity, and computer modeling of a molecular inclusion complex containing rifaldazine

Tan Q, He D, Wu M, Yang L, Ren Y, Liu J, Zhang J

International Journal of Nanomedicine 2013, 8:477-484

Published Date: 1 February 2013

Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin

Sun S, Liang N, Kawashima Y, Xia D, Cui F

International Journal of Nanomedicine 2011, 6:3049-3056

Published Date: 28 November 2011

The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration

Joerg Tautenhahn, Ralf Lobmann, Brigitte Koenig, Zuhir Halloul, Hans Lippert, Thomas Buerger

Vascular Health and Risk Management 2008, 4:683-689

Published Date: 30 June 2008

Adherence treatment factors in hypertensive African American women

Marie N Fongwa, Lorraines S Evangelista, Ron D Hays, David S Martins, David Elashoff, et al

Vascular Health and Risk Management 2008, 4:157-166

Published Date: 6 March 2008

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study

Erland Erdmann, John Dormandy, Robert Wilcox, Massimo Massi-Benedetti, Bernard Charbonnel

Vascular Health and Risk Management 2007, 3:355-370

Published Date: 4 October 2007

Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus

Toshihiro Tsuruda, Johji Kato, Takahiro Sumi, Kazuya Mishima, Hiroyuki Masuyama, Hiroyuki Nakao, Takuroh Imamura, Tanenao Eto, Kazuo Kitamura

Vascular Health and Risk Management 2007, 3:417-423

Published Date: 4 October 2007